The latest research in CTDs and Neurology, listed from most recent (top of list) to older resources (bottom of list).
Listings include a link embedded in the name of the study, the year it was published, and a credit to the group member who shared it with us.
Dyslexia and the Developing Brain, Molly McDonough for the Harvard Medicine Magazine, December 2023
‘Hidden Hearing Loss’ May Cause Tinnitus: Study, Ralph Ellis for Medscape, December 2023
Neurologic Nuggets of Wisdom for Pediatric Practice, Heidi Splete for Medscape, October 2023
Soft optical fibers block pain while moving and stretching with the body, The fibers could help with testing treatments for nerve-related pain. Jennifer Chu for MIT News, October 2023.
What Is Vagus Nerve Stimulation For? by Stephanie Pappas for Scientific American, July 2023, via Jon R.
‘Impressive’ Results for Intranasal Ketamine in Chronic, Refractory Migraine Eve Bender for Medscape Medical News, June 2023, via Jon R.
Dual Treatment May Boost Efficacy in Chronic Migraine, by Fran Lowry for Medscape Medical News, June 2023, via Jon R.
New Guidance on Neurological Complications of Long-COVID, Alicia Ault for Medscape, May 2023, via Jon R.
Cluster, Migraine Headache Strongly Linked to Circadian Rhythm Megan Brooks for Medscape, March 2023
A new mitochondrial theory of Alzheimer’s deserves serious attention A “grand unifying theory” of brain ageing suggests malfunctioning mitochondria might be to blame for Alzheimer’s and other brain conditions. And this new avenue of exploration already has some potential therapies at the ready. by New Scientist, March 2023, via Jon R.
Tethered cord syndrome in KBG syndrome, the American Journal of Medical Genetics, February 2023, via Debbie M.
Dietary Zinc Linked to Reduced Migraine Risk, Medscape, January 2023 via Jon R.
New strategy shows potential to block nerve loss in neurodegenerative diseases, “Blocking this molecular executioner prevents axon loss, which has been implicated in many neurodegenerative diseases, from peripheral neuropathies to Parkinson’s disease, and glaucoma to amyotrophic lateral sclerosis (ALS).” Broad Institute, October 2022 via Jon R.
Scientists Uncover Nearly All Genetic Variants Linked to Height, Largest genome-wide association study achieves ‘the impossible’, A. DiCorato, OBroad Institute, October 2022 via Jon R. (A saturated map of common genetic variants associated with human height, Nature)
Ehlers-Danlos, Proprioception, Dystonia, Dysautonomy, L-Dopa and Oxgenotherapy’s Efficacy, research study that was published back in 2019 by a team at the Occupational Therapy Institute in France in the Journal of Alzheimers & Neurodegenerative Diseases and posted by the Herald Scholarly Open Access Journal, via Monica C.
Neurological manifestations of Ehlers-Danlos syndrome(s): A review 2014 via PGD
Epilepsy in Ehlers-Danlos syndrome 1999 via PGD
Headache in Ehlers-Danlos syndrome 1999 via PGD
EDS and CTD New England/MA Support Group 
Leave a comment